TrialBMJ (Clinical research ed.)2021

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.

Michael J Kovacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.